Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds

2012 ◽  
Vol 133 (2) ◽  
pp. 174-180 ◽  
Author(s):  
Fabio Pagella ◽  
Elina Matti ◽  
Francesco Chu ◽  
Alessandro Pusateri ◽  
Carmine Tinelli ◽  
...  
1999 ◽  
Vol 109 (1) ◽  
pp. 15-20 ◽  
Author(s):  
Wolfgang Bergler ◽  
Frank Riedel ◽  
Antonio Baker-Schreyer ◽  
Cathrin Juncker ◽  
Karl Hörmann

2006 ◽  
Vol 20 (4) ◽  
pp. 421-425 ◽  
Author(s):  
Fabio Pagella ◽  
Lucia Semino ◽  
Carla Olivieri ◽  
Sabrina Corno ◽  
Roberto Dore ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Linxia Xu ◽  
Feng Xu ◽  
Qizhi Wang ◽  
Xiquan Ke

Abstract Background Hereditary hemorrhagic telangiectasia is an autosomal dominant hereditary hemorrhagic disease. Its main feature is an abnormal structure of the blood vessel wall. Cirrhosis of the liver is a common chronic progressive disease with one or more causes in which diffuse liver damage occurs after long-term or repeated injury. Liver cirrhosis can cause dilation of gastrointestinal capillaries. Many patients with hereditary hemorrhagic telangiectasia accompanied by gastrointestinal vascular malformations and liver cirrhosis may be diagnosed only with liver cirrhosis if the clinician does not pay attention to physical examination findings and family history. Moreover, general treatment measures, such as blood transfusion, iron supplementation, and application of hemostatic drugs, are less effective for bleeding in patients with hereditary hemorrhagic telangiectasia than in those with liver cirrhosis alone. Case presentation Here, we report the rare case of a 75-year-old Chinese man who was admitted to the hospital with repeated melena and epistaxis. He was diagnosed with unexplained liver cirrhosis, which was later confirmed as hereditary hemorrhagic telangiectasia. Subsequently, we implemented the treatment intervention of oral thalidomide combined with gastrointestinal argon plasma coagulation. A follow-up of more than 8 months showed that the treatment effect was excellent. Conclusions If patients with liver cirrhosis and gastrointestinal vascular malformations also have a family history of epistaxis, special attention should be paid to targeted physical examination results, and the possibility of hereditary hemorrhagic telangiectasia should be considered. Moreover, for patients with hereditary hemorrhagic telangiectasia and both gastrointestinal bleeding caused by gastrointestinal capillaries and repeated epistaxis, when other general treatment measures are ineffective, thalidomide combined with gastrointestinal argon plasma coagulation may be an effective intervention.


2014 ◽  
Vol 4 ◽  
pp. 249-253 ◽  
Author(s):  
Dariusz Waniczek ◽  
Jerzy Rdes ◽  
Marek K. Rudzki ◽  
Jerzy Piecuch ◽  
Nina Rubicz ◽  
...  

CHEST Journal ◽  
2008 ◽  
Vol 134 (4) ◽  
pp. 24C
Author(s):  
Ashutosh Sachdeva ◽  
Matthew Paparo ◽  
Christin L. Weller ◽  
Ravi P. Nayak

Sign in / Sign up

Export Citation Format

Share Document